Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zhengzhou Yuance Biotechnology is a specialized biotechnology company headquartered in Zhengzhou, China, dedicated to the production of high-purity recombinant proteins and antibodies. The company leverages advanced expression platforms, including bacterial, yeast, insect, and mammalian cell systems, to supply a comprehensive catalog of cytokines, growth factors, and enzymes. Beyond its product portfolio, Yuance Biotechnology offers tailored contract research services (CRO) such as custom protein expression and purification for global academic and industrial clients. Their offerings are critical for research in fields like immunology, oncology, and stem cell biology. The company also supports the diagnostic industry by providing essential raw materials for ELISA and other immunoassay kits. Through continuous innovation in protein engineering, they aim to provide cost-effective solutions for life science researchers worldwide.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Zhengzhou Yuance Biotechnology.